IL26 and COVID-19: Notably, the concentrations of IL-26 in plasma were higher in males than in females with COVID-19 (Figure 2A) and the number of plasma samples with a concentration of IL-26 above the LLOD were higher (χ2 test: p = 0.0187) in males than in females with COVID-19 (Figure 2B).